KTBS 3: CHAMPION-AF study of the WATCHMAN FLX™ Left Atrial Appendage Closure Device as a first-line therapy for stroke risk reduction meets all primary and secondary safety and ... Data highlights the WATCHMAN FLX device provided statistically superior protection from bleeding, demonstrated similar efficacy compared to blood thinners in patients with non-valvular atrial fibrilla ... CHAMPION-AF study of the WATCHMAN FLX™ Left Atrial Appendage Closure Device as a first-line therapy for stroke risk reduction meets all primary and secondary safety and ...
Medical Device and Diagnostic Industry (MD+DI): Boston Scientific Eyes Market Expansion with Watchman FLX After CHAMPION-AF Success A new Watchman device at McLaren Port Huron offers eligible AFib patients an alternative to long‑term blood thinners to help reduce stroke risk. The Cottage Heart & Vascular Center’s structural heart team at Santa Barbara Cottage Hospital (SBCH) recently performed their 1,000th WATCHMAN device procedure, a minimally invasive solution for ... Boston Scientific stock tumbled Monday on mixed test results for its Watchman device in patients at risk of having a stroke. News Medical: WATCHMAN Device helps reduce stroke risk, stop use of blood thinners in patients with atrial fibrillation WATCHMAN Device helps reduce stroke risk, stop use of blood thinners in patients with atrial fibrillation
